91 – 100 of 105
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2021
-
Mark
Comment on: EPIDEMIOLOGY OF BIOPSY-CONFIRMED GIANT CELL ARTERITIS IN SOUTHERN SWEDEN-AN UPDATE ON INCIDENCE AND FIRST PREVALENCE ESTIMATE: Reply
- Contribution to journal › Article
-
Mark
Multiple manifestations of systemic sclerosis affect walk distance
- Contribution to journal › Letter
-
Mark
Comment on : Negative associations for fasting blood glucose, cholesterol and triglyceride levels with the development of giant cell arteritis: Reply
- Contribution to journal › Letter
-
Mark
Incidence of extra-articular manifestations in ankylosing spondylitis, psoriatic arthritis and undifferentiated spondyloarthritis : Results from a national register-based cohort study
- Contribution to journal › Article
-
Mark
Impact of the COVID-19 pandemic on morbidity and mortality in patients with inflammatory joint diseases and in the general population : A nationwide Swedish cohort study
- Contribution to journal › Article
-
Mark
Influence of the age at diagnosis in the disease expression of primary Sjögren's syndrome. Analysis of 12,753 patients from the Sjögren Big Data Consortium
- Contribution to journal › Article
- 2019
-
Mark
Validity of polymyalgia rheumatica diagnoses and classification criteria in primary health care
- Contribution to journal › Article
-
Mark
PREDICTORS OF EROSION AND JOINT SPACE NARROWING PROGRESSION IN PATIENTS WITH EARLY RHEUMATOID ARTHRITIS
- Contribution to journal › Published meeting abstract
-
Mark
PREDICTORS OF CLINICAL EFFICACY OF ABATACEPT IN RHEUMATOID ARTHRITIS: DATA FROM A LARGE OBSERVATIONAL STUDY
(2019) EULAR 2019
- Contribution to conference › Abstract
- 2016
-
Mark
Reumatiska sjukdomar och osteoporos
(2016) p.483-534
- Chapter in Book/Report/Conference proceeding › Book chapter
